During regular trading hours, there were many stocks that continued to break up to the upside. These stocks are usually going up with news.If you are looking to day trade also check out my Top 2011 Stock Gainers , Stocks to Buy 2012.You can also check previous stocks to buy reports- Right Here today.Hot stocks Today Right Here.I also have technical analysis different stocks-Right Here. Market Technical analysis Right Here
Quick Look Market Closing Price:
At the close: Dow +0.64% to 12841. S&P +0.71% to 1353. Nasdaq +1% to 2939.
Treasurys: 30-year -0.31%. 10-yr -0.12%. 5-yr -0.12%.
Commodities: Crude +1.43% to $106.2. Gold +0.79% to $1685.35.
Currencies: Euro +0.27% vs. dollar. Yen +0.32%. Pound -0.1%.
After Hours News:
Flotek Industries (FTK): Q4 EPS of $0.20 beats by $0.05. Revenue of $74.9M (+57.7% Y/Y) beats by $1M. Shares +6.1% AH.
AMAG Pharmaceuticals (AMAG) +6.8% AH after announcing positive preliminary results for the first of 2 Phase III studies for its Feraheme drug. The results suggests Feraheme could be effective in treating iron deficiency regardless of its cause, rather than simply for kidney disease. AMAG plans to submit a supplemental NDA to the FDA that would allow it to expand Feraheme's addressable market
Kratos Defense & Security Solutions (KTOS): Q4 EPS of $0.17 beats by $9,25. Revenue of $218M (+80.2% Y/Y) misses by $12M. Shares +0.4% AH.
Hot Topic (HOTT): Q4 EPS of $0.21 beats by $0.01. Revenue of $210M (-1.2% Y/Y) in-line. Shares +3.5% AH
AMAG Pharmaceuticals (AMAG) +6.8% AH after announcing positive preliminary results for the first of 2 Phase III studies for its Feraheme drug. The results suggests Feraheme could be effective in treating iron deficiency regardless of its cause, rather than simply for kidney disease. AMAG plans to submit a supplemental NDA to the FDA that would allow it to expand Feraheme's addressable market
Kratos Defense & Security Solutions (KTOS): Q4 EPS of $0.17 beats by $9,25. Revenue of $218M (+80.2% Y/Y) misses by $12M. Shares +0.4% AH.
Hot Topic (HOTT): Q4 EPS of $0.21 beats by $0.01. Revenue of $210M (-1.2% Y/Y) in-line. Shares +3.5% AH
Sigma Designs (SIGM): Q4 EPS of -$0.43 misses by $0.14. Revenue of $35.6M (-49.6% Y/Y) misses by $2M. Shares -1.3% AH
Semtech (SMTC): Q4 EPS of $0.32 beats by $0.02. Revenue of $71.1M (-10.6% Y/Y) beats by $7M. Shares -0.2% AH
Semtech (SMTC): Q4 EPS of $0.32 beats by $0.02. Revenue of $71.1M (-10.6% Y/Y) beats by $7M. Shares -0.2% AH
Pall (PLL): FQ2 misses on all counts despite an 8.2% Y/Y rise in revenue growth. Sales increased across all segments, with good growth in its Life Sciences and Industrial units. On a global basis, emerging market sales grew over 20% in local currency driven by the Energy markets in MENA and Latin America. Shares -1.9% AH
SunPower (SPWR) says its CFO Dennis V. Arriola resigned on March 5th. The company's board has appointed Charles Boynton acting CFO until a replacement is found. Shares -1.2% AH
Amylin Pharmaceuticals (AMLN) -4.8% AH after announcing a 13M share stock offering. The drug developer says it will use the proceeds to help commercialize its recently-approved Bydureon diabetes drug
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
